1 0 0 8 VOLUME 16 | NUMBER 8 | AUGUST 2013 nature neurOSCIenCe a r t I C l e S Once formed during early development, neurons are retained for life and are therefore faced with the challenge of maintaining a stable genome for long periods of time. DNA damage, which perturbs genomic stability, has been linked to cognitive decline in the aging human brain 1 , and mutations in DNA-repair genes manifest profoundly with neurological implications 2 . Recent studies have suggested that DNA damage is also elevated in disorders such as Alzheimer's disease and amyotrophic lateral sclerosis [3] [4] [5] . However, the precise mechanisms connecting DNA damage with neurodegeneration remain poorly understood.
a r t I C l e S
Once formed during early development, neurons are retained for life and are therefore faced with the challenge of maintaining a stable genome for long periods of time. DNA damage, which perturbs genomic stability, has been linked to cognitive decline in the aging human brain 1 , and mutations in DNA-repair genes manifest profoundly with neurological implications 2 . Recent studies have suggested that DNA damage is also elevated in disorders such as Alzheimer's disease and amyotrophic lateral sclerosis [3] [4] [5] . However, the precise mechanisms connecting DNA damage with neurodegeneration remain poorly understood.
Sirtuins are NAD + -dependent lysine deacetylases that modulate a number of biological processes that are highly relevant to aging and neurodegeneration 6 . We previously reported that overexpression of SIRT1, the archetypal mammalian sirtuin, confers protection against neuronal loss in the transgenic CK-p25 mouse model of neurodegeneration 7 ; however, the mechanisms underlying this protection were unclear. CK-p25 mice express a truncated fragment of the CDK5-activating partner, p35, in an inducible and forebrain-specific manner 8 , and p25 induction systematically recapitulates various neurodegenerative pathologies, including the accumulation of amyloid-β peptides, neurofibrillary tau tangles, reduced synaptic density and neuronal atrophy in the forebrain 8, 9 . Notably, further characterization of CK-p25 mice revealed that the occurrence of DSBs precedes all other pathological symptoms in these mice 10 . To understand how SIRT1 is able to suppress neuronal loss, we directly characterized the functions of SIRT1 in the neuronal DNA DSB response.
RESULTS

SIRT1 is essential for DSB signaling and DNA repair in neurons
To determine whether SIRT1 is essential for genomic stability in neurons, we transduced neurons cultured from mouse embryos carrying loxP-flanked Sirt1 (Sirt1 loxP/loxP ) with a lentiviral vector carrying Cre recombinase tagged with enhanced GFP (Cre-eGFP) to delete Sirt1 (Supplementary Fig. 1a ) and assessed DNA damage using a singlecell electrophoresis assay (comet assay) 11 . A significant fraction of Sirt1 loxP/loxP neurons transduced with Cre-eGFP (hereafter referred to as Sirt1 knockout neurons) showed comet tails even without treatment with an exogenous DNA-damaging agent (Fig. 1a) . In the presence of the DSB-inducing drug etoposide, Sirt1 knockout neurons had longer 'tail moments' compared to controls transduced with a vector carrying nonfunctional Cre (eGFP) (Fig. 1a) . These results suggest that neurons lacking SIRT1 are more susceptible to DNA damage. In addition, whereas the tail moments in etoposide-treated control neurons were significantly reduced after recovery for 16 h, Sirt1 knockout neurons continued to have long comet tails, suggesting that Sirt1 knockout neurons are also deficient in DSB repair (Fig. 1a) . To verify this, we used a reporter assay system ( Supplementary  Fig. 1b,c) 12 in which reconstitution of a functional GFP gene indicates successful DSB repair through the nonhomologous end-joining (NHEJ) pathway. In this assay, the number of GFP + neurons was significantly reduced after SIRT1 knockdown (Fig. 1b) , confirming that SIRT1 is necessary for NHEJ-mediated DSB repair in neurons. a r t I C l e S Notably, despite the elevated amounts of DNA damage (Fig. 1a) , phosphorylation of H2AX (γH2AX) was reduced (by at least 30%) in Sirt1 knockout neurons that were challenged with etoposide ( Fig.  1c) . We obtained similar results in neurons pretreated with the SIRT1 inhibitor sirtinol (Supplementary Fig. 1d ), and together these findings suggest that initial events in DSB signaling could be disrupted in the absence of SIRT1 activity. To address this possibility, we first used the rare-cutting homing endonuclease I-PpoI to generate DSBs at defined loci within the genomes of cultured primary neurons 13, 14 . Chromatin immunoprecipitation (ChIP) after I-PpoI induction revealed that the occupancy of phosphorylated ATM and NBS1, key DSB sensors and transducers, is attenuated at chromatin proximal to I-PpoI-generated DSBs in Sirt1 knockout neurons (Fig. 1d) . ATM is rapidly activated through autophosphorylation after DSB induction and in turn coordinates signaling events at DSBs through phosphorylation of its numerous targets, including H2AX 15 . In addition to being deficient in ATM recruitment, the amounts of phosphorylated ATM were also markedly reduced in etoposide-treated Sirt1 knockout neurons compared to controls (Fig. 1e) , indicating that SIRT1 is also essential for ATM activity. Taken together these results suggest that SIRT1 is an apical component of the neuronal DSB response whose activity is crucial for the initial sensing and signaling from DSBs and their eventual repair through NHEJ.
SIRT1 interacts physically with HDAC1
We previously showed that overexpression of the class I histone deacetylase, HDAC1, could also suppress neuronal loss during p25 expression 10 . Because both SIRT1 and HDAC1 were able to suppress neuronal loss in the same mouse model, we reasoned that the two proteins might work collaboratively to promote genomic stability in neurons. Incubation of purified recombinant Flag-tagged HDAC1 (HDAC1-Flag) with recombinant histidine-tagged SIRT1 (SIRT1-His) followed by the precipitation of HDAC1 with anti Flag-conjugated agarose beads coprecipitated SIRT1, suggesting a direct physical interaction between SIRT1 and HDAC1 (Fig. 2a) . Notably, HDAC2, which shares ~85% similarity with HDAC1, was unable to bind SIRT1 under the same conditions (Fig. 2a) . Next we generated and expressed multiple Flag-tagged fragments of HDAC1 (Fig. 2b) and mapped the interaction to the N-terminal domain (NTD) of HDAC1 (Fig. 2c) . Notably, immunoprecipitation of endogenous HDAC1 indicated only weak binding with endogenous SIRT1 (Fig. 2d) , but this interaction was considerably strengthened by induction of DNA damage (Fig. 2d) .
Because an interaction between SIRT1 and HDAC1 is stimulated by DNA damage, we inquired whether SIRT1 and HDAC1 localize to sites of DNA DSBs in neurons. Colocalization analysis of cultured primary neurons revealed that SIRT1 and HDAC1 show a punctate distribution pattern that is devoid of chromocenters (subnuclear compartments consisting of densely packed chromatin) and nucleoli in mouse primary neurons. After treatment with etoposide, a substantial fraction of SIRT1 and HDAC1 colocalized with γH2AX foci (Fig. 2e) , suggesting that both SIRT1 and HDAC1 are present at sites of DSBs in neurons. We next used laser microirradiation to generate subnuclear DSBs within the nuclei of individual Hoechst-stained primary neurons ( Supplementary Fig. 2a,b) . After microirradiation, both SIRT1 and HDAC1 showed strong enrichment within lesioned regions that were marked with γH2AX (Fig. 2f) . In addition, we again used the I-PpoI system and targeted a unique I-PpoI cleavage site within the Dnahc7b locus on chromosome 1 for ChIP analysis. As described above (Fig. 1d) , we detected a strong enrichment in phosphorylated ATM at chromatin proximal to the I-PpoI cleavage site after I-PpoI induction (Fig. 2g) . The amounts of SIRT1 and HDAC1 were also enriched at damageproximal chromatin after DSB generation, with pATM, SIRT1 and HDAC1 showing the strongest accumulation immediately 3′ to the cleavage site (Fig. 2g) . Together these results suggest that SIRT1 and HDAC1 are recruited to sites of DNA DSBs in neurons. 
Figure 1 SIRT1 is necessary for initial DSB signaling events and DNA repair in neurons. (a) DNA damage assessed using a comet assay in Sirt1 loxP/loxP neurons infected with lentiviral vectors carrying either functional Cre recombinase (Cre-eGFP) or nonfunctional Cre (eGFP) that were treated with 5 µM etoposide (ETP) for 1 h and either allowed to recover (Rec.) for 16 h in the absence of etoposide or lysed immediately. Scale bar, 100 µm. The graph shows the comet tail moments (***P < 0.001, n = at least 50 neurons per condition, one-way analysis of variance (ANOVA)). AU, arbitrary units. (b) The number of GFP + cells (indicating NHEJ-mediated repair) in cultured primary neurons that were transfected with a predigested NHEJ reporter construct ( Supplementary Fig. 1b,c) npg a r t I C l e S To further investigate the dynamics of SIRT1 and HDAC1 recruitment to DSB sites, we microirradiated Hoechst-stained primary neurons expressing either EmGFP-SIRT1 or HDAC1-EmGFP and monitored their localization to sites of laser-induced DSBs as a function of time. We detected an increase in EmGFP-SIRT1 accumulation in laser-lesioned regions almost immediately after DSB induction (τ 1/2 = 3.21 ± 0.48 s (mean ± s.e.m.)) (Fig. 3a-c) , whereas HDAC1-EmGFP accumulation became apparent by ~60 s (τ 1/2 = 57.7 ± 5.8 s), indicating that SIRT1 localizes to DSB sites with faster kinetics than HDAC1. Next we individually knocked down various known DSB sensors and assessed their effects on SIRT1 and HDAC1 dynamics at laser-induced DSBs in live postmitotic neurons. The recruitment of SIRT1 to DSBs was strictly ATM dependent, and knockdown of ATM caused a marked reduction in both the maximal intensity and the kinetics of SIRT1 accrual at DSBs ( Fig. 3d and Supplementary Fig. 2c ). Thus, SIRT1 and ATM have a mutually dependent relationship, with SIRT1 being essential for ATM stability at DSBs and ATM activity after DSB induction (Fig. 1d,e) and ATM being necessary to recruit SIRT1 to DSBs. Conversely, the accumulation of HDAC1 was most severely affected by the knockdown of NBS1 and KU70 and KU80 (KU70/80) (Fig. 3d) , with the latter also causing HDAC1 to accrue with slower kinetics (Supplementary Fig. 2c) . Moreover, HDAC1 is probably recruited as part of the nucleosome remodeling and deacetylase (NuRD) complex, as knockdown of CHD4, an integral component of the NuRD complex, also severely disrupted HDAC1 localization to DSBs (Fig. 3d) 16 . Knockdown of individual DSB sensors had no effect on the expression of either EmGFP-SIRT1 or HDAC1-EmGFP (Supplementary Fig. 2d) .
Overall, distinct proteins seemed to govern SIRT1 and HDAC1 recruitment to DSBs. However, because an interaction between SIRT1 and HDAC1 is enhanced by DNA damage and SIRT1 localizes to DSBs with faster kinetics than HDAC1, we tested the effect of SIRT1 knockdown on HDAC1 localization to laser-generated DSBs. In neurons transfected with SIRT1 short interfering RNAs (siRNAs), HDAC1 localization to laser-induced DSBs was markedly reduced (Fig. 3e) , suggesting that in addition to the above factors, SIRT1 is also essential for HDAC1 recruitment. In corroboration with this finding, HDAC1 enrichment at I-PpoIgenerated DSBs was also significantly diminished in Sirt1 knockout neurons (Fig. 3f) . Together these experiments describe the dynamics of SIRT1 and HDAC1 in response to DSB formation in living neurons, unveil a new synergistic relationship between SIRT1 and ATM that is crucial for signaling at DSBs and identify a new interaction between SIRT1 and HDAC1 that helps recruit HDAC1 to DSBs. npg a r t I C l e S
SIRT1 deacetylates HDAC1 and stimulates its enzymatic activity
Although an important function of the physical interaction between SIRT1 and HDAC1 could be to facilitate the recruitment of HDAC1 to DSB sites ( Fig. 3e,f) , HDAC1 is acetylated by the p300 acetyltransferase, and acetylation of HDAC1 inhibits its deacetylase activity 17 .
We therefore posited that the interaction of SIRT1 with HDAC1 might lead to the deacetylation and activation of HDAC1. Incubation of recombinant HDAC1 with increasing amounts of p300 recapitulated the previous observation that p300 acetylates HDAC1 ( Supplementary  Fig. 3a ) 17 , whereas titration of SIRT1 in the HDAC1-p300 reactions decreased the acetylation of HDAC1 in a dose-dependent manner (Fig. 4a) . In addition, whereas overexpression of HDAC1 together with p300 resulted in increased HDAC1 acetylation, coexpression of SIRT1 caused marked HDAC1 deacetylation ( Fig. 4b) , suggesting that SIRT1 can deacetylate HDAC1. We next determined whether SIRT1-mediated deacetylation of HDAC1 affects its enzymatic activity. In a fluorescence-based reporter assay (Supplementary Fig. 3b ), incubation of recombinant HDAC1 with p300 caused an approximate 40% reduction in HDAC1 activity, whereas its activity was stimulated by about 30% in the presence of SIRT1 (Fig. 4c) . In addition, immunoprecipitated HDAC1 from Sirt1 knockout neurons showed a significant deficit in enzymatic activity compared to HDAC1 precipitated from control neurons (Fig. 4d) . Conversely, SIRT1 overexpression resulted in stimulation of HDAC1 activity (Supplementary Fig. 3c ). Together these results suggest that SIRT1-mediated deacetylation of HDAC1 stimulates its activity.
To specifically determine the residues within HDAC1 that are deacetylated by SIRT1, we incubated recombinant HDAC1 with either p300 alone or p300 and SIRT1 as described above and subjected the reaction mixtures to analysis by mass spectrometry. In the presence of p300 alone, HDAC1 was readily acetylated at residues Lys89, Lys220, Lys412, Lys432, Lys438, Lys439 and Lys441 ( Fig. 4e-g ). Labelfree quantification indicated that the addition of SIRT1 resulted in decreased acetylation at all sites except Lys412 (Fig. 4g) . Moreover, we did not detect acetylation at two of these residues, Lys220 and Lys432, using the mass spectrometry assay, suggesting substantial deacetylation activity of SIRT1 on the two acetyl-lysine residues (Fig. 4g ). An antibody that specifically recognizes acetylated Lys432 of HDAC1 (ref. 18 ) and quantitative western blotting further confirmed the ability of SIRT1 to deacetylate HDAC1 at this residue (Fig. 4h) . Similarly, treatment of HEK293T cells with a pharmacological SIRT1 activator (compound #10) 19 decreased HDAC1 acetylation at Lys432 in a dose-dependent manner (Fig. 4i) . Furthermore, in a computationally predicted tertiary structure of HDAC1 (Supplementary Fig. 3d ), the proximity of the region containing Lys432 to the NTD indicates that the binding of SIRT1 at the NTD could allow for deacetylation of residues at the C terminus. (I rel ) as a function of time at lesioned ROIs for neurons expressing HDAC1-EmGFP together with either scrambled siRNA or SIRT1 siRNA (***P < 0.001, n = at least 10 independent measurements per condition, unpaired t test). (f) The recruitment of the indicated proteins to cleavage sites within the Rna28s1 locus assessed using ChIP (as in Fig. 1d ) after DSBs were generated using the I-Ppol-estrogen receptor (ER) system in wild-type (WT) and Sirt1 knockout primary neurons (*P < 0.05, n = 3, unpaired t test). Error bars (b,d-f), s.e.m.
npg a r t I C l e S
Of all the acetylatable residues in HDAC1, Lys432 has been shown to be particularly important for its enzymatic activity, and mutation of this residue to an acetyl-mimetic glutamine (K432Q) almost completely abolished HDAC1 activity 17 . Moreover, whereas the remaining lysines are conserved between HDAC1 and the closely related HDAC2, Lys432 in HDAC1 is occupied instead by arginine in HDAC2 (Fig. 4e) , and HDAC1, but not HDAC2, can be acetylated by p300 (refs. 17,20) . Taken together these results suggest that in addition to facilitating the recruitment of HDAC1 to DSB sites, SIRT1 also exists in an enzyme-substrate relationship with HDAC1 wherein SIRT1 deacetylates HDAC1 at a crucial lysine residue, Lys432, thereby stimulating its enzymatic activity. 
HDAC1
Figure 4 SIRT1 deacetylates HDAC1 at residue Lys432 and stimulates its enzymatic activity. (a) HDAC1 acetylation assessed by western blotting of recombinant SIRT1 that was titrated over a fixed amount of p300 and HDAC1 (*P < 0.05, n = 3, one-way ANOVA). KAc, acetylated lysine. (b) Immunoprecipitation and acetylation status of HDAC1 (probed using an antibody to acetylated lysine) in HT22 cells expressing HDAC1-Flag, hemagglutinin-tagged p300 (p300-HA) or SIRT1-Myc. (c) Enzymatic activity of HDAC1 that was preincubated with either p300 or SIRT1, as in a and b, assessed using a fluorescence-based HDAC enzymatic activity assay ( Supplementary Fig. 3b ) (**P < 0.01, n = 3, one-way ANOVA). (d) Immunoprecipitation and enzymatic activity of HDAC1, as in c, in Sirt1 loxP/loxP neurons that were infected with Cre-eGFP and eGFP lentiviral vectors (*P < 0.05, n = 3, unpaired t test). (e) Diagram depicting the acetylated lysine residues in HDAC1 and HDAC2. (f) Annotated tandem mass spectrometry spectrum of the lysineacetylated peptide NSSNFK ac K ac AK ac R (where subscript ac denotes acetylation) that identified lysine acetylation sites at Lys438, Lys439 and Lys441 of HDAC1 after reaction with p300. The b and y ions represent collision-induced peptide fragment ions containing the N or C terminal, respectively. The asterisks indicate fragment ions with neutral loss of amine. (g) Label-free quantification for each lysine acetylation site using a protein abundancenormalized peptide-precursor ion intensity showing that lysine acetylation abundance on p300-treated HDAC1 decreased after the addition of SIRT1 to the reaction. Ac, acetylation of the indicated lysine. (h) Acetylation of HDAC1, as in a, of recombinant SIRT1 that was incubated together with p300 and HDAC1 assessed using an antibody specific to acetylated Lys432. The arrowheads indicate nonspecific cross-reacting bands in the lanes containing recombinant SIRT1 (*P < 0.05, n = 3, unpaired t test). (i) HDAC1 acetylation at Lys432 in HEK293T cells that were treated with the indicated concentrations of the SIRT1 activator compound #10 for 12 h. Error bars (a,c,d,h,i), s.e.m.
a r t I C l e S
HDAC1 deacetylation by SIRT1
To understand whether HDAC1 deacetylation has a role in DSB signaling and repair in neurons, we characterized the effects of HDAC1 loss in these processes. In comet assays, Hdac1 knockout neurons had longer tail moments than controls and, similarly to Sirt1 knockout neurons (Fig. 1a) , were unable to recover from etoposide-induced DSBs (Fig. 5a ). This suggests that neurons become more susceptible to DSBs in the absence of HDAC1 and that HDAC1 is essential for DSB repair in neurons. In contrast to SIRT1, however, HDAC1 had no effect on ATM autophosphorylation (Supplementary Fig. 4a ), and γH2AX intensity was increased in Hdac1 knockout neurons compared to controls after etoposide treatment (Supplementary Fig. 4b ). We obtained similar results in cultured primary neurons expressing a catalytically inactive HDAC1, HDAC1 H141Y (Supplementary Fig. 4c ). Thus, although HDAC1 is essential for DNA repair in neurons, initial events in DSB signaling such as ATM and H2AX phosphorylation do not require HDAC1 activity. These results are consistent with the notion that HDAC1 functions downstream of SIRT1 in the DSB response. We next assessed the status of HDAC1 acetylation in Sirt1 knockout neurons after etoposide treatment. Whereas HDAC1 acetylation at Lys432 was increased in etoposide-treated control neurons, this increase was far more pronounced in Sirt1 knockout neurons (Fig. 5b) , suggesting that the acetylation of HDAC1 is modulated in response to DSB formation and that SIRT1 maintains HDAC1 in a deacetylated and active state in neurons. However, given that HDAC1 is essential for DSB repair, we found it peculiar that the acetylation of HDAC1 is elevated after DSB formation. To further clarify this matter, we briefly treated cultured primary neurons with etoposide (30 min) followed by washout and recovery in etoposide-free medium. We then prepared lysates at hourly intervals and monitored HDAC1 acetylation at Lys432 as a function of time after etoposide treatment. Notably, compared to untreated controls, neurons treated with etoposide for 30 min showed a reduction in Lys432 acetylation (Fig. 5c) . This trend continued until 1 h after etoposide washout, after which time the amount of acetylated Lys432 began to rise again, surpassing the amount of acetylation in untreated controls by about 4 h after washout (Fig. 5c) . Furthermore, this pattern of HDAC1 acetylation mirrored changes in the acetylation of histone H4 Lys16 (H4K16) (Fig. 5c) , a previously identified HDAC1 target 21 , and the amount of H4K16 acetylation was increased in Hdac1 knockout neurons (Supplementary Fig. 4d) .
To further understand the importance of HDAC1 deacetylation in the DSB response, we overexpressed eGFP-tagged variants of HDAC1 carrying either a K432Q (acetylation mimetic) or a K432R (acetylation resistant) mutation in cultured primary neurons. In control neurons expressing eGFP alone, etoposide treatment readily triggered the formation of γH2AX foci, and consistent with previous observations, overexpression of HDAC1-EmGFP caused a reduction in the number of γH2AX foci (Fig. 5d) . In contrast, neurons expressing the K432Q mutant showed γH2AX foci even in the absence of etoposide treatment and a substantial increase in the number of foci in the presence of etoposide (Fig. 5d) . Conversely, neurons expressing the K432R mutant had a modest reduction in γH2AX intensity compared to controls, indicating that constitutive acetylation of HDAC1 renders neurons more susceptible to genotoxic insults, especially DSBs.
Because SIRT1 stimulates HDAC1 through deacetylation, we predicted that the acetyl-mimetic HDAC1 K432Q mutant would also be refractory to the effects of SIRT1 overexpression. In the presence of etoposide, neurons overexpressing SIRT1 showed a significant Figure 5 Deacetylation of HDAC1 is essential for DSB repair in neurons. (a) DNA damage assessed using the comet assay in Hdac1 loxP/loxP neurons that were infected as in Figure 1a and treated with etoposide (***P < 0.001, n = at least 50 neurons per condition, one-way ANOVA). Scale bar, 100 µm. (b) HDAC acetylation at Lys432 assessed by western blotting of primary neurons cultured from Sirt1 loxP/loxP embryos that were infected as in Figure 1a and treated with 5 µM etoposide for 2 h (*P < 0.05, n = 3 independent experiments, one-way ANOVA). (c) Western blot analysis probing the indicated acetylation marks in cultured primary neurons (7 d in vitro) that were treated with 5 µM etoposide for 30 min, after which the cells were lysed either immediately or after recovery from etoposide washout for the indicated times and electrophoresed. Untr, untreated. (d) Staining with antibodies to γH2AX of primary neurons that were transfected with the indicated vectors and treated with etoposide (2 µM) for 1 h. Scale bar, 10 µm (*P < 0.05, ***P < 0.001, n = at least 25 neurons per condition and 4 independent experiments, one-way ANOVA). (e) As in d but using cultured primary neurons expressing SIRT1-Flag together with either HDAC1-EmGFP or HDAC1 K432Q -EmGFP that were treated with etoposide (2 µM) for 1 h. Scale bar, 15 µm. The quantification is shown to the right (*P < 0.05, n = at least 25 neurons per condition and 3 independent experiments, one-way ANOVA). (f) The number of GFP + cells (assessed as a measure of DNA repair using NHEJ) of cultured primary neurons expressing either SIRT1 together with HDAC1 shRNA that were transfected with the predigested NHEJ reporter construct (*P < 0.05, n = 3 independent experiments, one-way ANOVA). Error bars (a,b,d-f), s.e.m. npg a r t I C l e S reduction in the number of γH2AX foci compared to controls (data not shown); however, SIRT1 overexpression had little effect on γH2AX intensity in neurons also expressing the HDAC1 K432Q mutant (Fig. 5e) . Similarly to SIRT1 overexpression, treatment of neurons with the pharmacological SIRT1 activator also caused a reduction in γH2AX intensity (Supplementary Fig. 4e,f) , and neurons expressing the K432Q and K432R mutants were also refractory to a SIRT1 activator-mediated reduction in γH2AX intensity (Supplementary Fig. 4f) . Mutation of the lysine residue to glutamine had no effect on the ability of HDAC1 to bind SIRT1 (Supplementary Fig. 4g ). However, expression of the NTD fragment of HDAC1, which would compete with endogenous HDAC1 for SIRT1 binding, resulted in increased γH2AX intensity compared to controls (Supplementary Fig. 4f) . Also, SIRT1 activator treatment could not stimulate the activity of purified recombinant HDAC1 directly in the absence of SIRT1 (Supplementary Fig. 4g ). We again used the fluorescence-based NHEJ reporter system wherein we transfected the predigested reporter construct in neurons expressing SIRT1 together with either a control short hairpin RNA (shRNA) or HDAC1 shRNA. SIRT1 overexpression in neurons stimulated NHEJ-mediated DSB repair, as indicated by an increase in GFP + cells compared controls (Fig. 5f) . However, this increase was attenuated in neurons expressing HDAC1 shRNA (Fig. 5f) . Taken together these results suggest that the ability of SIRT1 to protect against DNA damage and stimulate DNA repair requires it to interact with and deacetylate HDAC1.
On the basis of these observations, we assessed whether SIRT1 activation also affects the number of DSBs and HDAC1 acetylation in neurodegenerating CK-p25 mice by orally administering the pharmacological SIRT1 activator to these mice. Western blot analysis of hippocampal lysates after 6 weeks of p25 induction revealed a sharp reduction in HDAC1 Lys432 acetylation in the CK-p25 mice that we treated with the SIRT1 activator compared to CK-p25 mice treated with a vehicle control (Fig. 6a) . In addition, whereas vehicle-treated CK-p25 mice had a marked increase in the number of γH2AX-positive cells in the hippocampus, the number of γH2AX-positive cells was reduced by about 40% in CK-p25 mice administered the SIRT1 activator (Fig. 6b) . These results suggest a strong correlation between SIRT1 activation, HDAC1 deacetylation and a reduction in the number of DNA DSBs. Additionally, administration of the SIRT1 activator was also able to reduce HDAC1 acetylation and γH2AX intensity in 2-month-old human tau transgenic (P301S) mice 22 (Fig. 6c,d ).
Together these results highlight the therapeutic potential of SIRT1 activators against neurodegeneration.
DISCUSSION
Overall our data suggest that SIRT1 primes the cellular response to DNA DSBs by stimulating the activities of ATM and HDAC1. After being recruited to DSBs in an ATM-dependent manner, SIRT1 in turn stimulates ATM autophosphorylation and ATM recruitment to DSB sites and thereby primes the cellular DSB signaling cascade ( Supplementary  Fig. 5 ). After DSB induction, the MRE11-RAD50-NBS1 complex is known to activate ATM through an interaction between NBS1 and ATM 23 . SIRT1 also interacts with and deacetylates NBS1 (ref. 24) , and NBS1 recruitment to DSBs is compromised in Sirt1 knockout neurons (Fig. 1d) . It is therefore intriguing to consider the SIRT1-NBS1 interaction as a potential mechanism of ATM activation. However, ATM is also known to be an acetylated protein 25 , and an equally interesting possibility involves SIRT1-mediated deacetylation of ATM being important for ATM autophosphorylation and activity.
In addition to activating ATM, SIRT1 participates in conjunction with KU70/80, NBS1 and the NuRD complex to stabilize HDAC1 at DSB sites. Furthermore, SIRT1 deacetylates and stimulates HDAC1, thus facilitating the dynamic regulation of HDAC1 activity that is essential for DSB repair through NHEJ. Our data are consistent with the notion that HDAC1 functions in DNA repair by affecting chromatin configuration through epigenetic modification. For instance, acetylation of H4K16 and H3K56 decrease in an HDAC1-and HDAC2-dependent manner after DSB induction, and the inability to deacetylate these residues results in more relaxed chromatin and decreased amounts of DNA repair 21, 26 . However, an 'open' chromatin configuration is also important for repair because it allows repair proteins to access damaged sites easily 26 . The 'closed' chromatin configuration (probably mediated by HDAC1 and other proteins) in the initial stages after DSB formation could allow for the broken DNA ends to be retained in close proximity and for transcriptional silencing in their vicinity, after which controlled 'opening' of the chromatin could grant access to repair and signaling factors. The dynamic modulation of HDAC1 activity through its acetylation and the biphasic pattern of H4K16 acetylation (Fig. 5c) 21 are consistent with such a model. We demonstrate a r t I C l e S here that one arm of such modulation is conferred by SIRT1, which deacetylates and activates HDAC1. The other arm, probably involving an acetyltransferase that inactivates HDAC1, awaits discovery. Several histone acetyltransferases (HATs), including p300, hMOF and TIP60, are known to function in the DNA DSB response [27] [28] [29] . Moreover, these HATs are also deacetylated by SIRT1, and SIRT1-mediated deacetylation has been shown to inhibit their HAT activity 30, 31 . The importance of these interactions in chromatin organization and signaling at DSBs is only beginning to be unraveled, and although our work emphasizes the role of the SIRT1-HDAC1 connection in DSB repair, the relative importance of SIRT1-mediated deacetylation of the above-mentioned substrates warrants further investigation. In neurodegenerative disorders such as Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis, the major risk factor is age itself 32 . Microarray analysis of postmortem human brain samples has revealed that genes encoding for synaptic transmission, learning and memory are downregulated after age 45, and this is associated with elevated amounts of oxidative damage in the promoters of the downregulated genes 1 . In addition, DNA DSBs and an upregulation of DNA damage-response genes precede the emergence of all other Alzheimer's disease-like neuropathological hallmarks in CKp25 mice 10 , and elevated amounts of DNA strand breaks have been observed in the Alzheimer's disease brain 3 . Together these results raise the possibility that the accrual of DNA damage with age could underlie the pathological changes that are associated with neurological disease. SIRT1 is known to directly modulate synaptic plasticity and memory formation 33 , and SIRT1 redistribution in response to chronic DNA damage is thought to underlie some of the transcriptional changes in the aging brain 34 . Considering these observations, the benefits conferred by pharmacological activation of SIRT1 could be substantial.
METHODS
Methods and any associated references are available in the online version of the paper.
Note: Supplementary information is available in the online version of the paper.
For primary neurons, dissociated cortical neurons dissected from embryonic day 16-18 Swiss-Webster mice were plated at a density of 500,000 cells per well in 24-well plates, 2 million cells per plate in 35-mm glass bottom plates and 15 million cells per plate in 10-cm plates. The plates were coated beforehand by incubation with poly-d-lysine (0.05 mg ml −1 ) and laminin (0.005 mg ml 1 ) for 1 h at 37 °C followed by washing twice with dH 2 O. Neurons were maintained in neurobasal medium (Gibco, 21103) supplemented with l-glutamine (5 mM), penicillin and streptomycin and B27 neuronal additive. Phenol red-free neurobasal medium (Gibco, 12348) was used as a substitute for the neuron cultures used in live-imaging experiments.
Cell lines and primary neuron cultures were transiently transfected using Lipofectamine 2000 reagent (Invitrogen, 11668) for at least 1 h in medium lacking antibiotics, after which cells were washed in warmed medium and given at least 24 h to allow for construct expression before usage. For live-imaging experiments using siRNA, 0.75 µg siRNA was cotransfected with either HDAC1-EmGFP or EmGFP-SIRT1 and given 48 h to allow for sufficient knockdown before imaging. For viral gene transduction, the virus was added directly to the culture medium. I-PpoI-ER was induced by adding 4-hydroxytamoxifen (Sigma, H7904) to a final concentration of 1 µM and incubated for 6 h before fixation.
western blotting and immunoprecipitation. For both primary neurons and cell lines, 1.5-2 × 10 6 cells were washed once with PBS and lysed for 10 min on ice in RIPA buffer (150 mM NaCl, 1% IGEPAL, 0.5% NaDOC, 0.1% SDS and 50 mM Tris, pH 8.0, supplemented with protease inhibitors) on the plates in which they were originally grown. Cells were then collected by scraping and were rotated for 30 min at 4 °C. Supernatant was collected after centrifugation (13,000 r.p.m., 10 min, 4 °C). For each sample, SDS protein loading buffer was added to 1× and boiled (95 °C, 10 min) before loading onto a 10% sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) gel. Gels were transferred to polyvinylidene fluoride membranes (200 mA constant current) and blocked with 3% bovine serum albumin (BSA) in PBS plus Tween-20 (PBS-T) for 1 h before application of primary antibodies. Membranes were visualized with either electrochemiluminescence and autoradiographic film detection or the LiCor Odyssey quantitative western imaging system.
For immunoprecipitations, 1 mg of total protein lysate was used for each condition and brought to a total volume of 500 µl with RIPA buffer. The appropriate antibody was then added, and the mixture was incubated on a rotator overnight at 4 °C. As required, protein A/G-conjugated agarose beads (GE Health Science, 17-5280/17-0618) or Flag M2 affinity gel (Sigma, A2220) were equilibrated with RIPA buffer, blocked overnight with 3% BSA and washed before adding to the samples. For all immunoprecipitations, a total volume of 30 µl of bead slurry was used per reaction mix. The reaction mixtures were incubated for 1 h at 4 °C, after which they were washed four times and denatured by boiling (95 °C, 10 min) in RIPA buffer containing 1× SDS sample buffer.
Immunostaining, image acquisition and analysis. For immunostaining, cells were fixed by incubating with 4% paraformaldehyde for 10 min at room temperature and incubated with blocking buffer (5% normal donkey serum and 0.3% Triton X-100 in PBS) for 1 h. Primary antibodies were diluted in blocking buffer and incubated with cells overnight at 4 °C. Primary antibodies were visualized using the appropriate secondary antibodies conjugated to Cy2, Cy3 and Cy5 fluorescent dyes (Jackson ImmunoResearch Laboratories Inc., 1:500, 711-545-152, 711-165-152, 715-485-150, 715-165-150). Images for all fixed cells were acquired on a Zeiss LSM510 laser-scanning confocal microscope and subsequently deconvolved using theoretical point spread functions generated in ImageJ along with the Tikhonov-Miller iterative image restoration algorithm, which was implemented in the DeconvolutionLab plug-in written for ImageJ 40 . To assess and analyze images in a quantitative and unbiased manner, CellProfiler automated image analysis software 41 was trained to measure the per-cell γH2AX signal from a minimum of 100 cells per condition for all imaging experiments. For experiments using tagged proteins, CellProfiler was trained to consider transfected cells exclusively for quantification. Colocalization was assessed using ICA computation, which highlights pixels either negatively or positively covarying between two input channels. A plug in implementing this technique has been written as a plug-in for ImageJ and is freely available for download (http://imagej. nih.gov/ij/plugins/mbf/).
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Image processing and analysis for microirradiation live imaging. All data acquired from microirradiation time lapses were processed according to the iterative deconvolution strategy described above before analysis. Normalized relative fluorescence (I rel ) within the 2-µm 2 rectangular-strip ROI was quantified for each time point using a computation that compensates for both background signal and fluorescence loss due to observational bleaching 42 . τ 1/2 values were extracted from I rel values by first converting them into fractional fluorescence values as described previously 43 , and Prism5 was then used to plot and fit curves to this data.
HdAc1 structural modeling and tertiary structure prediction. The I-TASSER (http://zhanglab.ccmb.med.umich.edu/I-TASSER/) computational protein structure prediction algorithm was used to generate a three-dimensional predicted model for HDAC1 (refs. 44,45) . The mouse HDAC1 (NP_032254) amino acid sequence and the crystal structure from the ancient HDAC1 ancestor, HDLP (RCSB Protein Data Bank ID 1C3P) 46 , were used as inputs for processing by the I-TASSER algorithm. Output structure coordinates were processed and formatted in PyMOL, and amino acids were color coded to correspond to the HDAC1 functional domain schematic.
In vivo drug administration. Mice were administered oral doses of 30 mg per kg body weight SIRT1 activator (compound #10) for 4 weeks. Dosage determination was based on pharmacokinetic studies that optimized for brain penetrance and minimal side effects. Oral gavage was performed using 1.5-inch, curved, 20-gauge, stainless steel feeding needles with a 2.25-mm ball (Braintree Scientific). Twice-daily gavage treatments were performed between the hours of 8 a.m. to 10 a.m. and 4 p.m. to 7 p.m. microirradiation and live imaging. Microirradiation was performed as described previously 47 on 7 d in vitro mouse primary cortical neurons using a Zeiss LSM710 inverted laser scanning confocal microscope. Cells were maintained in a controlled and stable environment for the duration of the imaging sessions. At least 24 h were allowed in transfected cells for construct expression.
chIP. For ChIP, 1.5 × 10 6 cells were subjected to a two-step dual crosslinking procedure as described previously 48, 49 . Purified DNA was analyzed by quantitative PCR (qPCR) using a BioRad CFX-96 quantitative thermocycler and SsoFast EvaGreen Low-ROX qPCR SuperMix (BioRad). Data were analyzed using the ∆∆C T method (Applied Biosystems).
Single-cell electrophoresis (comet) assays. Cultured primary neurons were treated with 5 µM etoposide for 1 h and either allowed to recover for 16 h or dissociated immediately using 0.025% trypsin-ethylenediaminetetraacetic acid (EDTA). Dissociated neurons were embedded in a thin layer of low-melting agarose (0.5%), lysed and subjected to single-cell gel electrophoresis under alkaline conditions 11 .
In vitro binding and acetylation and deacetylation reactions. For binding reactions, anti-Flag-conjugated agarose beads (Sigma) were resuspended in 100 µl binding buffer (50 mM Tris-HCl (pH 7.5 at 25 °C), 5 mM MgCl 2 , 1 mM EDTA, 100 mM NaCl, 0.05% NP-40 and 10% glycerol). HDAC1-Flag and SIRT1-His (1 µg each) were combined in reaction buffer (50 mM Tris-HCl (pH 7.5 at 25 °C), 1 mM dithiothreitol (DTT), 137 mM NaCl, 2.7 mM KCl, 4 mM MgCl 2 , 0.1 mM EDTA, 1 mM NAD + and 10% glycerol) and incubated at 37 °C for 1 h. Each reaction was then supplemented with 30 µl of bead slurry and 90 µl of binding buffer and incubated in a rotator overnight at 4 °C. The beads were then pelleted, washed, boiled in Laemmli SDS-PAGE loading dye and analyzed by SDS-PAGE. In the acetylation reactions (30 µl), 100 ng recombinant HDAC1-Flag was incubated together with recombinant p300-HA in a buffer containing 50 mM Tris (pH 8.0 at 25 °C), 1 mM DTT, 1 mM phenylmethanesulfonylfluoride (PMSF), 0.1 mM EDTA, 50 nM acetyl-CoA and 10% glycerol and was incubated at 30 °C for 1 h. For deacetylation reactions, acetylation reactions were first performed as described above, after which the reactions were supplemented with NaCl (137 mM final), KCl (2.7 mM final), MgCl 2 (4 mM final), NAD + (1 mM final) and recombinant SIRT1-His and incubated for 1 h at 37 °C. HDAC1 enzymatic activity was measured using a fluorimetric assay as described 50 . Before measuring HDAC1 activity, acetyl-CoA and NAD + in the reactions were removed through dialysis, and 5 mM nicotinamide was added to ensure SIRT1 inactivation.
liquid chromatography-mass spectrometry analysis. Gel bands containing HDAC1 were excised and in-gel digested using a protocol previously described 51 . The tryptic peptides were solubilized in high-performance liquid chromatography (HPLC) buffer A (0.1% formic acid in water) and loaded onto a capillary HPLC column (10 cm, 75 µm inside diameter) self-packed with Jupiter C12 resin (Phenomenex). Samples were separated using a 90-min linear gradient of 5-30% HPLC buffer B (0.1% formic acid in acetonitrile) and analyzed by an LTQ Orbitrap Velos mass spectrometer (Thermo Fisher Scientific Inc.). The tandem mass spectrometry data were analyzed with the Mascot search engine (Matrix Science, v2.1) with a Mascot cutoff score of 10 and P < 0.05 and with subsequent manual verification. Label-free quantification was performed for each lysine acetylation site on the basis of peptide precursor ion intensity normalized by protein abundance ratios.
Statistical methods. Standard statistical methods consistent with previous reports using similar assays, techniques and methods were used to analyze all data 11, 14, 21, 47 . No statistical methods were used to predetermine sample sizes, but our sample sizes were similar to those reported in previous publications 10, 13, 21 . Analysis of γH2AX intensity in CK-p25 and tau P301S mice after treatment with SIRT1 activator were performed blind to the conditions of the experiment. For most other analyses, data collection and analysis were not performed blind to experimental conditions. Data were collected and processed randomly and appropriately blocked. The data distributions were assumed to be normal, but this was not formally tested.
